T-cell acute lymphoblastic leukemia · 2 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone N/A - intrathecal component | — | R 21 728 | 28d | — | — | — | — | — |
Daunorubicin, Pegaspargase, Vincristine, Dexamethasone N/A - intrathecal component | — | R 67 | 28d | — | — | — | — | — |
2 of 2 regimens shown